Coronary Artery Disease Therapeutics Market Analysis-2027

1. CORONARY ARTERY DISEASE THERAPEUTICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Coronary Artery Disease Therapeutics Market- Overview Coronary Artery Disease Therapeutics Market, by Drug Type (Beta Blockers, Calcium Channel Blockers, ACE Inhibitors, Nitrates, Statin, and Others), by End User, and by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 Coronary Artery Disease (CAD) is a medical condition developed due to damaged or diseased blood vessels, which supply blood, nutrients, and oxygen to the heart. Coronary heart disease is characterized by deposition of cholesterol plague in the arteries, which results into inflammation. Increasing deposition of plague eventually narrows the coronary arteries thereby decreasing the blood flow to the heart. Decrease of blood flow to the heart causes shortness of breath and chest pain leading to heart attack after complete blockage. Coronary artery disease is caused by smoking, high blood pressure, high cholesterol, diabetes or insulin resistance, sedentary lifestyle, and hypertension. Other factors involved in developing coronary artery disease include obesity, physical inactivity, high stress, and unhealthy diet. Coronary artery disease can be prevented by maintaining healthy diet, consumption of low fat and low salt fruits and vegetables, physical activity, and management of stress. Treatment of coronary artery disease includes cholesterol modifying medications, ACE inhibitors, Aspirin, beta blockers, Calcium channel blockers, and Ranolazine.. Surgeries conducted to treat coronary artery disease include Nitroglycerin, Angioplasty, and coronary artery bypass surgery Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/coronary-artery-disease-therapeutics-market-1799 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Coronary Artery Disease Therapeutics Market Drivers:- The global market is expected to witness significant growth due to robust pipeline of drugs over the forecast period (2018-2026). For instance, hydroxychloroquine sulfate tablets sponsored by first affiliated hospital of Xi’an Jiaotong university, China is in the fourth phase of clinical trials, this drug suppresses symptoms of coronary artery disease. Atorvastatin sponsored by university health network, Toronto has completed phase two clinical trials in 2014, this drug reduces the risk of heart attack and myocardial infraction. PADMA 28 sponsored by University hospital Inselsiptal, Berne has completed phase 2 clinical trials in 2013, this drug has beneficial effect on arterial system, the autonomic nervous system and blood inflammatory markers in patients with coronary artery disease. Furthermore, approval of new drugs for coronary artery disease is another factor driving growth of the coronary artery disease therapeutics market. For instance, in 2016, the U.S. FDA approved Yosprala (Aspirin and Omeprazole) by Aralez Pharmaceuticals, a Canada- based company, this drug is used to prevent cardiovascular diseases. In 2015, FDA approved Repatha by Amgen Inc. This drug is used to treat high cholesterol. In 2015, FDA approved Prestalia by Symplmed Pharmaceuticals LLC, this drug is used to treat hypertension for people suffering with heart disorders. Later in 2017, Prestalia was acquired by Marina Biotech Inc. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/1799 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION However, high cost of new drugs is restraining growth of coronary artery disease therapeutics market. For instance, Entresto was launched by Novartis, a U.S.-based company, indicated for preventing heart failures. It is priced at US$ 492 for 60 tablets, which is not affordable to low and middle income population. North America is expected to hold dominant position in global coronary artery disease therapeutics market due to high prevalence of coronary artery disease. According to a survey conducted by Centers for disease control and prevention (CDC), in 2015, coronary heart disease kills more than 370,000 people annually in the U.S. out of which more than 92% had chest pain as a major symptom. According to a study conducted by American College of Cardiology, in 2017, more than 790000 people experience heart attack annually in the U.S. out of this around 47% people were reported to have hypertension and around 34% were reported to have high blood pressure. Therefore, high prevalence of chronic diseases are expected to drive growth of this market over the forecast period. Asia Pacific coronary artery disease therapeutics market is projected to witness significant growth due to FDA approvals for generic drugs. For instance, in 2017, Lupin, India-based Company received FDA approval to launch generic version of Nadolol Tablets, indicated for the treatment of hypertension and angina pectoris. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1799 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved